3D Cd(II)-Based Complex with Photocatalytic Property and Treatment Activity on Endometrial Cancer

Abstract

A new metal–organic framework of [Cd3(4-Hpzc)2(4-pzc)2(DMF)2]n (1, 4-H2 pzc = 4-pyrazolecarboxylic acid, DMF = N, N′d-imethylformamide) was prepared via the solvothermal self-assembly reaction of 4-H2pzc and Cd(NO3)2 ·4H2O. The porous framework has a photonic band gap of 3.37 eV and has a good photocatalytic activation for methyl violet decomposition under ultraviolet irradiation. After obtaining this fresh compound with a special structure, its application value for the treatment of endometrial cancer was detected. First, the relative expression of IGFBP-rP1 on intrauterine cells was measured. Second, the activity of the PI3K-AKT signaling route in intrauterine cells was determined.